Cancure
  • Home
  • About
    • Vision
    • Board & Management
    • Scientific Advisors
  • Cancer
    • Current Treatments
    • Market
  • Therapies
    • Genvax – lead candidate CNC118
    • Galectin – lead candidate CNC225
    • Mitocans – lead candidate CNC332
    • Combination Therapy
    • Genvax vs. CAR-T
    • Development Program
    • References
  • Investors
    • Investors Snapshot
    • News
    • Public Documents
  • Contact
  • Glossary of Terms
  • Search
  • Menu Menu
cancure cancer treatments

INVESTORS SNAPSHOT

Name

Cancure Limited

Business Description

Cancure Limited is a clinical-stage cancer drug development company established to consolidate and capitalise on over a decade of immuno-oncology research and development. Cancure aims to maximise patient response rates and hasten the evolution of cancer treatments into cancer cures.

History

Established in 2012 on the Gold Coast, Queensland, Australia.

Company Structure

Public unlisted company with a small group of private shareholders committed to doing all that they can to support clinical and research efforts to advance Cancure’s breakthrough therapies to the market with the ultimate aim of eliminating cancer and saving lives.

Location

c/o Element Business & Accounting Solutions
Level 5, 33 Elkhorn Street
Surfers Paradise QLD 4217

Directors

Stephen Ralph
Sydney Evans
Craig Miles

Auditor

WPIAS Pty Ltd
4 Helensvale Road
Helensvale QLD 4212

Accountant

Jodie Mills
Small Myer Hughes Lawyers
Level 2, 17 Welch Street
Southport QLD 4215

Company Secretary

Craig Miles

  • Investors Snapshot
  • News
  • Public Documents

NEWS

  • NousCom receives $49M to trial off-the-shelf cancer vaccine
  • AstraZeneca bolts Incyte’s IDO1 immunomodulator to its lung cancer plans
  • Incyte pays MacroGenics $150M for PD-1 inhibitor
  • Gilead buys CAR-T developer Kite Pharma for $12B

Contact

Mr Craig Miles
craig@cancure.com
+61 (0) 408 778 797
PO Box 1177, Broadbeach,
Queensland, Australia 4218

Copyright © 2021 All rights reserved.
  • Twitter
  • Dribbble
Scroll to top